Retinoic Acid Derivatives

Acceptability at Recruitment

QUALIFIED

Acceptability at CT / Work-Up

QUALIFIED

Individual at Risk

Recipient

Explanation of Condition

A group of drugs used to treat a number of inflammatory conditions, such as acne or psoriasis.

However, they can cause severe congenital defects if given to pregnant women.

Guidance

Generally unacceptable if ever taken Etretinate (Tigason). Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register.

At CT, inform the transplant centre if a donor is taking these medications, or has done so at any point in the last 12 months.

Version

Version 1, Edition 1

Date of Last Update

15th June 2012